Previous reports have indicated the relevance of FcγR-dependent functions via., ADCC and ADCP in anti-CTLA-4 therapies (Arce Vargas et al., 2018; Ingram et al., 2018), which contributes to antitumor responses in mouse tumor models. The gene discussed is FCGR2A; the disease is neoplasm.